Literature DB >> 29436792

Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.

Hossein Ranjbaran1, Saeid Abediankenari1, Masoud Mohammadi1, Narjes Jafari2, Alireza Khalilian2, Zahra Rahmani3, Marzei Momeninezhad Amiri4, Pirooz Ebrahimi5.   

Abstract

Wharton`s jelly-derived mesenchymal stem cells (WJ-MSCs), have a high proliferation valency and they do not produce teratogen or carcinogen after subsequent transplantation. They are known as regenerative medicine. Thus more research is needed on the isolation and characterization of mesenchymal stem cells. In this experimental study, we obtained Wharton's jelly tissues from mothers during normal vaginal delivery, after obtaining their informed consent. Mesenchymal stem cells were isolated from cultured Wharton`s jelly, cultured, and were then examined for their proliferation, immunophenotypes, and differentiation capacities. The immunophenotypes of WJ-MSCs were analyzed by flow cytometry. Differentiation was performed resulting in osteogenic, chondrogenic and adipogenic cells. WJ-MSCs formed a homogenous monolayer of adherent spindle-shaped cells. Our results showed the high capacity of the proliferation of WJ-MSCs. Immunophenotyping further confirmed the purity of the isolated cells; their surface antigen expression showed the phenotypical properties like those of WJ-MSCs. The expanded cells were positive for CD 90, CD105, and CD44; they were negative for CD34 and HLA-DR surface markers. The cells had the adipocytic, osteocytic and chondrogenic differentiation capacity. The isolation and characterization of WJ-MSCs with high purity had been conducted, and the results were obtained in a short span. The present study has revealed the feasibility of the culture medium with high glucose and 15% FBS in isolation and proliferation of WJ-MSCs. When Wharton`s jelly pieces were put in the dry bottom of the flask, very effective separation of the MSCs was achieved.

Entities:  

Keywords:  Flow cytometry; Immunophenotyping; Mesenchymal stem cells; Wharton`s jelly

Mesh:

Year:  2018        PMID: 29436792

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  14 in total

Review 1.  Combination Therapy of Stem Cell-derived Exosomes and Biomaterials in the Wound Healing.

Authors:  Ali Golchin; Forough Shams; Arefeh Basiri; Parviz Ranjbarvan; Samaneh Kiani; Roya Sarkhosh-Inanlou; Abdolreza Ardeshirylajimi; Shiva Gholizadeh-Ghaleh Aziz; Sanaz Sadigh; Yousef Rasmi
Journal:  Stem Cell Rev Rep       Date:  2022-01-26       Impact factor: 6.692

2.  Extracellular vesicles derived from human Wharton's jelly mesenchymal stem cells protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers.

Authors:  Victor Bodart-Santos; Luiza R P de Carvalho; Mariana A de Godoy; André F Batista; Leonardo M Saraiva; Luize G Lima; Carla Andreia Abreu; Fernanda G De Felice; Antonio Galina; Rosalia Mendez-Otero; Sergio T Ferreira
Journal:  Stem Cell Res Ther       Date:  2019-11-20       Impact factor: 6.832

Review 3.  Preclinical Studies and Clinical Prospects of Wharton's Jelly-Derived MSC for Treatment of Acute Radiation Syndrome.

Authors:  Mayuri Bandekar; Dharmendra K Maurya; Deepak Sharma; Santosh K Sandur
Journal:  Curr Stem Cell Rep       Date:  2021-04-28

Review 4.  An Update on Mesenchymal Stem Cell-Centered Therapies in Temporomandibular Joint Osteoarthritis.

Authors:  Yifan Zhao; Liang Xie
Journal:  Stem Cells Int       Date:  2021-04-01       Impact factor: 5.443

Review 5.  Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities.

Authors:  Yun-Xing Fu; Jing Ji; Fang Shan; Jialing Li; Rong Hu
Journal:  Stem Cell Res Ther       Date:  2021-03-03       Impact factor: 6.832

6.  Synergistic inhibitory effect of human umbilical cord matrix mesenchymal stem cells-conditioned medium and atorvastatin on MCF7 cancer cells viability and migration.

Authors:  Reyhaneh Abolghasemi; Somayeh Ebrahimi-Barough; Abdolreza Mohamadnia; Jafar Ai
Journal:  Cell Tissue Bank       Date:  2022-01-05       Impact factor: 1.752

7.  Diagnosis of Cardiac Rehabilitation after Percutaneous Coronary Intervention in Acute Myocardial Infarction Patients by Emission Computed Tomography Image Features under Filtered Back Projection Reconstruction Algorithm.

Authors:  Yuan Lv; Suyu Zhao
Journal:  J Healthc Eng       Date:  2021-10-22       Impact factor: 2.682

Review 8.  Human Wharton's Jelly-Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials.

Authors:  Katarzyna Stefańska; Katarzyna Ożegowska; Greg Hutchings; Małgorzata Popis; Lisa Moncrieff; Claudia Dompe; Krzysztof Janowicz; Wojciech Pieńkowski; Paweł Gutaj; Jamil A Shibli; Walterson Mathias Prado; Hanna Piotrowska-Kempisty; Paul Mozdziak; Małgorzata Bruska; Maciej Zabel; Bartosz Kempisty; Michał Nowicki
Journal:  J Clin Med       Date:  2020-04-12       Impact factor: 4.241

9.  Efficacy of mesenchymal stem cell therapy on glucose levels in type 2 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Hossein Ranjbaran; Bahareh Mohammadi Jobani; Elham Amirfakhrian; Reza Alizadeh-Navaei
Journal:  J Diabetes Investig       Date:  2020-10-22       Impact factor: 4.232

10.  miR-196b-5p inhibits proliferation of Wharton's jelly umbilical cord stem cells.

Authors:  Xiao Han; Haoqing Yang; Huina Liu; Chen Zhang; Yangyang Cao; Zhipeng Fan; Ruitang Shi
Journal:  FEBS Open Bio       Date:  2020-12-08       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.